Sign in
CompletedNo phase

Clinical Trial of Type II Collagen vs. Sodium Hyaluronate Intra-articular Injection in Knee Osteoarthritis

Key facts

Who runs it
ATEMs
Where
South Korea4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
117 people enrolled
Started
27 Oct 2025
Ended
9 Sept 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • CartiSave
  • Hyalforte Injection
Record updated
30 October 2026

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • 1. Adults aged 19 years or older
  • 2. Patients who agreed to participate in the study and signed the informed consent form
  • 3. Patients whose target knee joint intended for investigational product injection meet all of the following conditions at the screening visit:; 1) Knee joint pain due to Osteoarthritis; 2) Kellgren-Lawrence (K-L) Grade I to III confirmed by X-ray examination; 3) 100 mm Visual Analogue Scale (VAS) pain score of 40mm or higher during activity; 4) Absence of significant pathological findings, such as tumors
  • 4. Patients who agree to use medically acceptable methods of contraception throughout the clinical trial period

Who cannot take part

  • 5. Patients who use corticosteroids as follows at the screening visit:; 1) intra-articular injection at the target knee within 3 months; 2) systemic drug use within 3 months; 3) intra-articular injection at a joint other than the target knee within 4 weeks; 4) topical use is permitted except the target knee
  • 6. Patients who have received analgesics or anti-inflammatory drugs within 48 hours prior to the screening visit
  • 8. Patients who have participated in other interventional studies within 30 days prior to the screening visit
  • 1. Patients with a known hypersensitivity or history of allergic reactions to the active substance or any components of the investigational medical device or comparator drug (e.g., porcrine-derived proteins)
  • 2. Patients or their family members with autoimmune diseases
  • 4. Patients with any of the following medical history or conditions at the screening visit:; 1) History of radiation therapy or cancer treatment within 2 years; 2) Severe knee trauma, surgery, or injection in the knee within 6 months that makes knee evaluation difficult; 3) Gout or calcium pyrophosphate deposition disease with onset within 6 months; 4) Severe intra-articular effusion; 5) Infectious disease requiring hospitalization for the administration of antibiotics; 6) Clinically significant, medically uncontrolled disease that may interfere with the study (e.g., hepatic, cardiac, renal, oncologic, diabetic, or psyshiatric disorders)
  • 3. Patients with inflammatory arthritis such as rheumatoid arthritis, lupus arthritis, or psoriatic arthritis
  • 7. Patients who are pregnant, breastfeeding, or planning to become pregnant during the trial
  • 9. Patients who are considered inappropriate for participation in this study based on the investigator's judgement

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this clinical trial is to evaluate the efficacy and safety of CartiSave compared with sodium hyaluronate in patients with knee pain.

The 2 groups in the trial

  • CartiSave (2mL)Treatment being tested

    Treatment: CartiSave

  • Sodium Hyaluronate(2mL)Existing treatment, for comparison

    Treatment: Hyalforte Injection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter, Randomized, Single-blind, Active-controlled, Parallel Clinical Trial to Evaluate the Efficacy and Safety of 'CartiSave' in Patients With Knee Joint Pain
Record updated
30 October 2026